Next-generation sequencing identifies CDKN2A alterations as prognostic biomarkers in recurrent or metastatic head and neck squamous cell carcinoma predominantly receiving immune checkpoint inhibitors

BACKGROUND: This study aimed to identify potential biomarkers in patients with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) and further probe the prognostic implications of CDKN2A mutations, particularly within a subset receiving immunotherapy. METHODS: In this retrospective...

Descripción completa

Detalles Bibliográficos
Autores principales: Xue, Liqiong, Tang, Wenbo, Zhou, Jiuli, Xue, Junli, Li, Qun, Ge, Xiaoxiao, Lin, Fengjuan, Zhao, Wei, Guo, Ye
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10627168/
https://www.ncbi.nlm.nih.gov/pubmed/37936609
http://dx.doi.org/10.3389/fonc.2023.1276009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10627168/
https://www.ncbi.nlm.nih.gov/pubmed/37936609
http://dx.doi.org/10.3389/fonc.2023.1276009

Ejemplares similares